Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Item Type
Language	English
Keywords
Author	Ido Shinji 井土 愼二
Abstract
Journal or Publication Title	Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Publisher
Volume
Number
Page Range
Year	2017
ISSN
DOI
URI